major depressive disorder
Showing NaN - NaN of 78
MDD Trial in United States (BCI-024: over-encapsulated Buspirone tablet 15 mg QD and BCI-049: over-encapsulated Melatonin tablet
Completed
- Major Depressive Disorder
- BCI-024: over-encapsulated Buspirone tablet 15 mg QD and BCI-049: over-encapsulated Melatonin tablet 3 mg QD
- +2 more
-
Garden Grove, California
- +8 more
Jun 17, 2014
MDD Trial in United States (SSRI + , Escitalopram + Bupropion SR, Venlafaxine XR + Mirtazapine)
Completed
- Major Depressive Disorder
- SSRI + placebo
- +2 more
-
Tuscaloosa, Alabama
- +14 more
Apr 21, 2014
MDD, Depression Trial in India, United States (TC-5214, Placebo)
Completed
- Major Depressive Disorder
- Depression
- TC-5214
- Placebo
-
Tuscaloosa, Alabama
- +50 more
Mar 14, 2014
MDD Trial in United States (desvenlafaxine succinate sustained-release 50 mg/day, desvenlafaxine succinate sustained-release 100
Completed
- Major Depressive Disorder
- desvenlafaxine succinate sustained-release 50 mg/day
- +2 more
-
Phoenix, Arizona
- +60 more
Dec 17, 2013
MDD Trial in United States (Combination Product: BCI-024 + BCI-049)
Completed
- Major Depressive Disorder
- Combination Product: BCI-024 + BCI-049
-
Garden Grove, California
- +8 more
Oct 24, 2013
MDD Trial in Canada, Mexico, United States (Vortioxetine, Placebo)
MDD Trial in United States (Aripiprazole+ ADT, Placebo+ ADT)
Completed
- Major Depressive Disorder
- Aripiprazole+ ADT
- Placebo+ ADT
-
Birmingham, Alabama
- +33 more
Nov 7, 2013
MDD Trial in United States (Antidepressant + Aripiprazole)
Completed
- Major Depressive Disorder
- Antidepressant + Aripiprazole
-
Mesa, Arizona
- +57 more
Nov 7, 2013
MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)
Completed
- Major Depressive Disorder
- Levomilnacipran ER
- Placebo
-
Birmingham, Alabama
- +50 more
Aug 22, 2013
Sleep Disorders, Obstructive Sleep Apnea, MDD Trial in United States (armodafinil, )
MDD Trial in Worldwide (TC-5214, Duloxetine, Placebo)
Terminated
- Major Depressive Disorder
- TC-5214
- +2 more
-
Beverly Hills, California
- +66 more
Nov 14, 2012
MDD Trial in United States (AZD2066, Placebo, Duloxetine)
MDD Trial in Canada, United States (Trazodone Hydrochloride (HCl) Extended-Release Tablets, Placebo)
Completed
- Major Depressive Disorder
- Trazodone Hydrochloride (HCl) Extended-Release Tablets
- Placebo
-
Birmingham, Alabama
- +36 more
Apr 24, 2012
MDD Trial in Worldwide (Placebo, fluoxetine, duloxetine)
Completed
- Major Depressive Disorder
- Placebo
- +2 more
-
Birmingham, Alabama
- +55 more
Mar 26, 2012
MDD Trial in United States (AZD7268, Escitalopram, Placebo capsules)
MDD Trial in United States (Escitalopram, Placebo)
Completed
- Major Depressive Disorder
- Escitalopram
- Placebo
-
Sacramento, California
- +27 more
Apr 4, 2012
EEG Biomarkers for Predicting Response to Antidepressant Therapy
Completed
- Major Depressive Disorder
-
Los Angeles, California
- +9 more
Mar 6, 2012
MDD, Psychotic Disorders Trial in United States (Mifepristone, matching )
Completed
- Major Depressive Disorder
- Psychotic Disorders
- Mifepristone
- matching placebo
-
Pico Rivera, California
- +22 more
Feb 14, 2012
MDD, Dysthymia, Depression Not Otherwise Specified Trial in San Diego, Bellevue (Lithium Carbonate, Placebo, Citalopram)
Completed
- Major Depressive Disorder
- +3 more
- Lithium Carbonate
- +2 more
-
San Diego, California
- +1 more
Aug 22, 2011
MDD Trial in Worldwide (Desvenlafaxine Succinate)
Completed
- Major Depressive Disorder
- Desvenlafaxine Succinate
-
Birmingham, Alabama
- +116 more
Apr 22, 2011
MDD Trial in United States (6(S)-5-MTHF (a Medical Food))
Completed
- Major Depressive Disorder
- 6(S)-5-MTHF (a Medical Food)
-
San Diego, California
- +10 more
Jun 7, 2010